title: Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up.
authors.affiliation: Division of Transplant Nephrology and Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5356.
authors.forename: C
authors.initials: C
authors.lastname: Ynares
authors.forename: H K
authors.initials: HK
authors.lastname: Johnson
authors.forename: T
authors.initials: T
authors.lastname: Kerlin
authors.forename: D
authors.initials: D
authors.lastname: Crowe
authors.forename: R
authors.initials: R
authors.lastname: MacDonell
authors.forename: R
authors.initials: R
authors.lastname: Richie
mesh_terms: D002102:Cadaver; D005190:Family; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology*; D016174:Hepacivirus; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis*; D018937:Hepatitis C Antibodies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000502:physiology*; D008111:Liver Function Tests; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies